About Mangeet Kaur Bouns
Mangeet’s keen interest in the stock market led her to become an investment researcher and financial journalist. Using her fundamental approach to analyzing stocks, Mangeet’s looks to help retail investors understand the underlying factors before making investment decisions.
She earned a bachelor's degree in finance from BI Norwegian Business School.
Recent Articles By Mangeet Kaur Bouns
3 Biotech Stocks Investors Are Watching for Future Growth
A wide range of applications across several sectors, supportive government initiatives, rapid technological advancements, and shifting market dynamics position the biotechnology industry for robust long-term growth. Given the industry’s bright outlook, biotech stocks MannKind (MNKD), Illumina (ILMN), and TG Therapeutics (TGTX) could be ideal watchlist additions for potential growth. Read on…
3 A-Rated Tech Stocks to Watch and Buy This Week
The technology industry’s prospects appear promising, fueled by the ever-growing demand for innovative tech solutions owing to growing digitalization across multiple sectors and ample technological breakthroughs. Thus, it could be wise to watch and buy top tech stocks LiveRamp (RAMP), Gilat Satellite Networks (GILT), and AstroNova (ALOT) this week. These stocks are rated A (Strong Buy) in our proprietary rating system. Read more…
3 Smart Pharma Picks Serving Gains
With rising healthcare expenditure, growing need for precision medicine, innovations in biologics and gene editing, and rapid adoption of advanced technologies, the pharma industry is well-poised for significant growth and expansion. Thus, quality pharma stocks Wave Life (WVE), Teva Pharmaceuticals (TEVA), and Collegium (COLL) could be smart buys for substantial gains. Keep reading…
Top 4 Pharma Stocks on the Rise for Potential Gains
Growing medical needs, surging demand for precision medicine, favorable regulatory climate, and rapid digital transformation would create promising growth opportunities for pharma companies. Hence, it could be wise to invest in top pharma stocks Johnson & Johnson (JNJ), Spero Therapeutics (SPRO), Ipsen (IPSEY), and Procaps Group (PROC) for solid gains. Read on…
Buy, Sell, or Hold? Analyzing 3 Software Stocks
The software industry’s prospects appear optimistic owing to the rapid digitalization of business processes across end-use sectors, increased data security risks, and technological breakthroughs. So, let’s determine if you should buy, sell, or hold software stocks: Fortinet (FTNT), Akamai Technologies (AKAM), and Commvault Systems (CVLT). Read on to know more…
3 Consumer Finance Stocks With Massive Buy Potential
The financial services industry’s outlook looks bright, fueled by growing demand for investment alternatives, enhanced loan and credit accessibility, and rapid digital transformation. Thus, it could be wise to invest in quality consumer finance stocks H&R Block (HRB), Yiren Digital (YRD), and Regional Management (RM) for substantial gains. Continue reading…
Danaher (DHR) vs. Stryker (SYK) - Analyzing Anticipated Q4 Earnings
With rapidly increasing healthcare demands, numerous technological breakthroughs, and advanced research and development, the medical industry is well-poised for remarkable growth and profitability. As medical companies Danaher (DHR) and Stryker (SYK) gear to report their fourth-quarter earnings tomorrow, let’s determine if these stocks are ideal buys ahead of earnings…
Top 3 Home Improvement Stocks for 2024 Growth
With rapid urbanization, rising disposable incomes, and shifting consumer preferences toward automated and sustainable solutions, the home improvement and goods industry is poised for significant long-term growth. Hence, it could be wise to buy top home improvement stocks Hooker Furniture (HOFT), Mohawk Industries (MHK), and HNI Corporation (HNI) this year. Continue Reading...
3 B-Rated Defense Stocks to Secure Now
Amid escalating geopolitical tensions, growing global defense spending coupled with technological advancements create growth opportunities for aerospace and defense companies. Thus, robust defense stocks Textron (TXT), Woodward (WWD), and Moog (MOG.A) could be ideal investments now. These stocks are rated B (Buy) in our proprietary rating system. Read on…